Next Article in Journal
A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
Previous Article in Journal
Outcomes of Geriatric Patients with Hepatocellular Carcinoma

Article Versions Notes

Curr. Oncol. 2022, 29(6), 4342-4353;
Action Date Notes Link
article xml file uploaded 17 June 2022 09:42 CEST Original file -
article xml uploaded. 17 June 2022 09:42 CEST Update
article pdf uploaded. 17 June 2022 09:42 CEST Version of Record
article html file updated 17 June 2022 09:43 CEST Original file
Back to TopTop